Quarterly news

Spring 2026 Issue

Photo by TOMOKO UJI on Unsplash

 

SPARTAN 2026 is

May 14 - 16 in Toronto

It isn't too late to register. The hotel block is now closed, but the Hilton can provide you with other options. Call them at 416-893-3456 for help with rooms.

Get your dancing shoes on!

Do you wonder what you have in common with Bollywood dancers? You'll find out at SPARTAN's 2026 annual meeting!

undefined

Member News

Thank you to Dr. Matthew Stoll who has held the SPARTAN reigns for the past two years.


Welcome to new board members:

  • Dr. Abhijeet Danve
  • Dr. Soha Dolatabadi
  • Dr. Ruth Napier
  • Dr. Jessie Walsh


Do you have something you'd like to share with SPARTAN members?


Email us with your news and accomplishments and you may be included in the May newsletter.

SPARTAN takes on Greece

SPARTAN members participated enthusiastically at ASAS 2026 meeting. Discussions about the CLASSIC study and new ASAS-SPARTAN Classification Criteria were stimulating.

Test your knowledge

Which country has the lowest prevalence of HLA B27?

A - South Korea

B - Japan

C - Saudi Arabia

D - Colombia

E - None of the above


Follow this link to answer this poll

Or follow the QR code below:

.

Hot off the press from our members



Bittar M, Lee YC, Deodhar A. Decoding pain in axial spondyloarthritis: Mechanisms, management, and future directions. Best Pract Res Clin Rheumatol. 2026 Apr 14:102150.


Letarouilly JG, Ribeiro AL, Torgutalp M, Poddubnyy D, Proft F. Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis? Best Pract Res Clin Rheumatol. 2026 Apr 10:102149.


Richard N, Pardo Pardo J, Mirza R, Aydin SZ, Bessette L, Mosher D, Boyd T, Chan J, Eder L, Passalent L, Karam E, Nair B, Hazlewood GS, Tse SML, Rumsey DG, Zummer M, Haroon N, Inman R, Gladman DD, Rohekar S. Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1. J Rheumatol. 2026 Apr 1:jrheum.2026-0227. 


Do you have a recent publication you would like featured? Send it for inclusion in the next newsletter.

 

SAA has announced their 2026 Jane Brickell Early Career Investigator grants will be opening for applications in May 1 - August 1, 2026. This annual award of $30,000 is awarded to MD and PhD at the level of instructor or assistant professor working at a US institution who have contributed to the care and understanding of SpA. Apply on their website.

Letter

from the chair

Dear SPARTAN Members,

 

Annual Scientific Meeting

As I write what will be my final newsletter as Chair of SPARTAN, I find myself feeling a mix of gratitude and excitement for what lies ahead. I look forward to handing the position to Dr. Nigil Haroon, who will assume responsibilities at the end of the SPARTAN Annual Scientific Meeting.

Speaking of, we are eagerly counting down to the 2026 Annual Meeting in Toronto, scheduled for May 14–16. The format is different this year compared to previous years. The review course is limited to a half-day session on MRI, with one and a half days of cutting-edge science designed with an international audience in mind. SPARTAN projects will be discussed Saturday morning, May 16th. Unlike in past years, the reception will take place the first night (Thursday, May 14), so that non-member attendees can participate with us and still depart on Friday after the conclusion of the scientific sessions.



Despite these differences, much will remain the same, including the poster session and tours, the great debate, and trainee abstracts. We anticipate that the 2027 annual meeting will return to a more familiar format, and decisions about subsequent meetings will be guided by member feedback—so please be sure to complete those post-meeting surveys!

 

Executive Director Transition

Many of you have already received the news of another leadership transition within SPARTAN. Lisa Spiegel will be retiring after 11 years of dedicated service, and we are thrilled to welcome Judy Wiles as our new Executive Director. Judy brings deep experience in rare disease communications, patient advocacy, and organizational leadership—most recently as Director of Research and Advocacy at Defeat Duchenne Canada and Director at Facet Communications, where she has spent over 15 years working at the intersection of science, advocacy, and community. She lives in the Toronto area and has already been actively engaged in planning for the upcoming Annual Scientific Meeting.

Both Judy and Lisa will be present in Toronto, which will, fittingly, mark Lisa’s final SPARTAN engagement.

 

Annual Meeting Funding Update

With meeting and other SPARTAN costs increasing each year, we want to share an update regarding future ASM support.

The good news: nothing will change for 2026. Registration and two nights of hotel accommodations will remain fully covered for all SPARTAN members, airfare will be reimbursed up to $600, and trainee members will continue to receive ground transportation support as well as support to attend the review course.

Beginning in 2027, we anticipate the need to scale back some support. We will involve members in these discussions and share details as plans evolve, but we wanted to provide early notice as we adapt to these changes.

 

CLASSIC Data Access for Secondary Analyses

We are excited to share a major upcoming opportunity for SPARTAN investigators. Once the primary CLASSIC data are published, the CLASSIC clinical and imaging database will become available to all SPARTAN members for secondary analyses. This resource represents one of the most extensive datasets in our field, and we hope it will catalyze new collaborations and discoveries.

Our goal is to launch access following the 2026 ASM, with an application form to be made available on our website. There will be costs associated with data access, although self- or foundation-funded projects will receive substantial discounts; submission of a request will be free. Both clinical and imaging datasets will be available.

More details will follow, but we wanted this opportunity on your radar as you plan future research.

 

I look forward to seeing you in Toronto!


Have time to be a SPARTAN mentor? Looking for a mentor?


Sign up for SPARTAN's STAMP mentorship program. Let us know what type of support you need or can give - we'll do the rest.

 
 

The History of axSpA

SpA In America

Most of the attribution of the early description of axial spondyloarthritis (axSpA) and reactive arthritis (ReA) came from Europe in the  late 19th and early 20th centuries. Actually, one of very early descriptions of arthritis associated with diarrheal illness came from America. Christopher Columbus was suggested as being afflicted with ReA in the early 1500’s. From the American Revolutionary war, there is a interesting description of likely ReA following dysentery occurring in the setting of the unsuccessful campaign of Generals Philip Schuyler and Benedict Arnold to capture Quebec in 1775 (3). “Unfortunately, diarrhea peaked at the worst possible time, before the long and muddy portage from the Kennebec to the Chaudiere. The army’s physician, 22-year-old Isaac Senter, set up a field hospital at the ‘‘Great Carrying Place’’ to care for ‘‘a formidable number’’ of men who were too weak to proceed. A significant but unspecified number of these soldiers also suffered from ‘‘rheumatism.’’ Dr Senter described one patient with the ‘‘most violent rheumatism I ever saw, not able to help himself any more than a newborn infant, every joint in his extremities inflexible and swelled to an enormous size’’(3). Brodie in the U.K. described a “classic” case of ReA in 1818. “This was a case in a man aged 45 years in 1817, presenting with urethral discharge, fever, joint swelling and inflammation of the eyes, which, as so often happens, relapsed six and nine months after the initial onset”. Brodie also cited four similar cases studied by him in 1809. So years before Hans Reiter and Fiessinger and LeRoy E described their first cases in 1916 (5,6), this disease was well established.

 
 
Facebook  X  Instagram